Clinical trials
Completed Phase 3 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 2 |
| 2002 | 6 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 5 |
| M.D. Anderson Cancer Center | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| Astex Pharmaceuticals, Inc. | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| St. Jude Children's Research Hospital | 3 |
| Amgen | 2 |
| Case Comprehensive Cancer Center | 2 |
| Celgene Corporation | 2 |
| Eastern Cooperative Oncology Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 71 |
| Leukemia, Myeloid, Acute | 35 |
| Leukemia | 33 |
| Leukemia, Myelomonocytic, Chronic | 21 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
| Myeloproliferative Disorders | 19 |
| Lymphoma | 18 |
| Hodgkin Disease | 16 |
| Lymphoma, Non-Hodgkin | 16 |
| Multiple Myeloma | 14 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.